2 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 2 | Terminated 2 |
Follow Spasticity: new trials by email Literature Review of Spasticity trials Research Report on Spasticity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity Phase 2; Low Dose MYOBLOC (10,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity, Cerebrovascular Accident | Phase 2 / Phase 3 | Terminated | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 32 | 2021-11-02 | 2026-05-27 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity Phase 2; Low Dose MYOBLOC (15,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity | Phase 2 / Phase 3 | Terminated | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 40 | 2019-12-17 | 2026-05-22 |
Brain Injuries, Traumatic (2) · Hemiplegia (2) · Muscle Spasticity (2) · Stroke (2) · Cerebral Palsy (1) · Multiple Sclerosis (1)
Brain Diseases (2) · Brain Injuries (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Craniocerebral Trauma (2) · Muscle Hypertonia (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Manifestations (2) · Paralysis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Clinical Trials, Phase II as Topic (2) · Clinical Trials, Phase III as Topic (2) · rimabotulinumtoxinB (2)
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC (2)
Hungary (2) · Poland (2) · United States (2)